Entero Therapeutics, Inc. (NASDAQ:ENTO – Get Free Report)’s share price was up 0.4% on Wednesday . The stock traded as high as $0.49 and last traded at $0.48. Approximately 12,216 shares were traded during mid-day trading, a decline of 80% from the average daily volume of 62,303 shares. The stock had previously closed at $0.47.
Entero Therapeutics Stock Up 0.4 %
The business has a fifty day moving average of $0.56 and a two-hundred day moving average of $0.51.
About Entero Therapeutics
Entero Therapeutics, Inc, a clinical-stage biopharmaceutical company, engages in the development of targeted and orally delivered therapies for the treatment of patients with gastrointestinal diseases. The company's pipeline candidates include latiglutenase, a targeted oral biotherapeutic for celiac disease designed to breakdown gluten into non-immunogenic peptides, currently under Phase 2 studies; and capeserod, a selective 5-HT4 receptor partial agonist under Phase 1 studies for the treatment of gastroparesis.
See Also
- Five stocks we like better than Entero Therapeutics
- The 3 Best Retail Stocks to Shop for in August
- 2 Stocks Riding the Dominance of America’s Natural Gas Exports
- What does consumer price index measure?
- Buffett’s on the Sidelines – Should You Follow?
- Insider Trading – What You Need to Know
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
Receive News & Ratings for Entero Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Entero Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
